Cooper Financial Group Acquires 274 Shares of Sanofi (NASDAQ:SNY)

Cooper Financial Group increased its holdings in shares of Sanofi (NASDAQ:SNY) by 2.1% during the fourth quarter, HoldingsChannel reports. The firm owned 13,332 shares of the company’s stock after buying an additional 274 shares during the period. Cooper Financial Group’s holdings in Sanofi were worth $643,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. Northwest Investment Counselors LLC bought a new position in Sanofi during the 3rd quarter valued at about $29,000. Concord Wealth Partners raised its holdings in shares of Sanofi by 157.8% during the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock valued at $34,000 after purchasing an additional 363 shares during the last quarter. Fortitude Family Office LLC lifted its position in Sanofi by 708.6% during the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after purchasing an additional 659 shares during the period. Sunbelt Securities Inc. boosted its holdings in Sanofi by 72.1% in the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after purchasing an additional 313 shares during the last quarter. Finally, Ashton Thomas Private Wealth LLC bought a new stake in Sanofi in the 2nd quarter worth approximately $51,000. 14.04% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on SNY. Citigroup raised Sanofi to a “strong-buy” rating in a report on Tuesday, September 17th. StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $57.50.

Sanofi Trading Down 0.2 %

Shares of SNY stock opened at $48.61 on Tuesday. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97. The firm has a fifty day moving average price of $48.62 and a 200-day moving average price of $52.11. The company has a market cap of $123.36 billion, a price-to-earnings ratio of 24.80, a PEG ratio of 1.23 and a beta of 0.57. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Friday, October 25th. The company reported $1.57 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $1.35. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The business had revenue of $13.44 billion during the quarter, compared to analysts’ expectations of $16.59 billion. During the same quarter in the prior year, the business posted $2.55 earnings per share. The business’s quarterly revenue was up 12.3% on a year-over-year basis. As a group, equities analysts predict that Sanofi will post 4.06 earnings per share for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.